Search for: "JOHNSON v. MERCK "
Results 41 - 60
of 110
Sort by Relevance
|
Sort by Date
9 Aug 2012, 5:00 am
Johnson & Johnson (?) [read post]
18 Jun 2012, 1:38 pm
Christopher v. [read post]
15 Jun 2012, 2:08 pm
Merck & Co., 2006 U.S. [read post]
13 May 2012, 4:46 pm
Speakers from GE Healthcare, Harvard, Hoffmann-LaRoche, Intel, Johnson & Johnson, Merck, MIT, Pfizer, Stanford and more will share their expertise on licensing to solve the innovation gap. [read post]
16 Apr 2012, 1:37 pm
” What Bayer, Merck, and the FDA expect consumers to do with that sort of equivocation is anybody’s guess. [read post]
3 Mar 2012, 6:48 am
Kendall v. [read post]
2 Mar 2012, 6:52 am
Johnson & Johnson (?) [read post]
2 Feb 2012, 8:53 pm
Johnson & Johnson (Ortho Evra) Deposition2008-07-22 Woods v. [read post]
28 Oct 2011, 7:00 am
Johnson & Johnson, 2011 WL 2003407, at *5 (E.D. [read post]
1 Sep 2011, 6:14 am
The claims against the remaining defendants, including Johnson & Johnson and Merck, are slated for trial starting later this year. [read post]
14 Aug 2011, 11:13 am
If a message conveyed by an ad is literally true or ambiguous, the plaintiff must prove actual deception or a tendency to deceive and it may do so with properly conducted consumer evidence (Johnson & Johnson-Merck Consumer Pharm., Co. v Rhone-Poulenc Rorer Pharm (1994)). [read post]
3 Aug 2011, 3:31 am
General EU – India agreement in WTO dispute raises bar for EU drug seizures (IP Watch) EU: CJEU rules on repackaging of pharma goods: Joined Cases C-400/09 and C-207/10 Orifarm and Paranova v Merck Sharp Dohme (Class 46) (IPKat) EU: Ophtal v Oftal Cusi- General Court upholds finding of no likelihood of confusion for identical goods in T-160/09 (Class 46) EU: The holiday is over: a close reading of the opinion in Medeva: Joined Cases C? [read post]
18 Jul 2011, 6:12 am
Johnson & Johnson-Merck Consumer Pharm. [read post]
14 Jul 2011, 2:00 am
-Disclosure Dedication Rule – subject matter disclosed but not claimed is dedicated to the public and cannot be recaptured under the DOE (Johnson & Johnson Assocs. [read post]
14 Jul 2011, 2:00 am
-Disclosure Dedication Rule – subject matter disclosed but not claimed is dedicated to the public and cannot be recaptured under the DOE (Johnson & Johnson Assocs. [read post]
7 Jul 2011, 2:31 pm
Merck & Co., 949 A.2d 223 (N.J. [read post]
2 Jun 2011, 12:46 pm
Robins Co., 738 P.2d 1210, 1227-28 (Kan. 1987) (applied to medical device); Johnson v. [read post]
28 Apr 2011, 3:18 pm
Brown v. [read post]
19 Apr 2011, 5:04 pm
Teva and ratiopharm (EPLAW) Fentanyl – Germany: Federal Court of Justice: Lessons to be learned for claim construction and novelty: Xa ZR 149/07 (Kluwer Patent Blog) Finasteride – France: Tribunale de Grande Instance de Paris: Murder me twice – Merck’s dosage regime patent held invalid again: Teva v Merck Sharp & Dohme (EPLAW) Gaviscon (Sodium alginate, Sodium bicarbonate, Calcium carbonate) – UK: Reckitt Benckiser fined £10.2 M for… [read post]
13 Apr 2011, 2:29 pm
Johnson & Johnson-Merck Consumer Pharm. [read post]
